83OA phase II study of durvalumab (MEDI4736) for previously treated patients with stage IV squamous NSCLC (SqNSCLC): Lung-MAP Sub-study SWOG S1400A
暂无分享,去创建一个
R. Herbst | K. Kelly | D. Gandara | H. Borghaei | V. Papadimitrakopoulou | M. Redman | S. Waqar | F. Robert | G. Kiefer | Shannon L. McDonough